Faeth Therapeutics, Inc. Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Faeth Therapeutics, Inc. (FTH) had Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment of $606.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment · last filed 2026-08-04
- 2026-06-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $606.00K.
- 2026-03-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $581.00K.
- 2025-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $540.00K.
- 2025-09-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $510.00K.
| Period end | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment as first filed |
|---|---|---|
| 2026-06-30 | $606.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $581.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $540.00K 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $510.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $480.00K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $448.00K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.50M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.14M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.00M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.86M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.73M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $1.59M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.57M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.58M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.44M 10-K · filed 2024-02-29 | $1.44M 10-K · filed 2023-03-29 |
| 2022-09-30 | $1.47M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.49M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.35M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.19M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $879.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $744.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $693.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $595.00K 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |